| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | CA2673601A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
| 07/03/2008 | CA2673466A1 Substituted tetracycline compounds |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/03/2008 | CA2671527A1 Process for preparing fluoromethyl-substituted heterocyclic compounds |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1939182A1 Process for the preparation of (R or S)-2-Alkyl-3-heterocyclyl-1-propanols |
| 07/02/2008 | EP1938686A1 Substituted 1-(3-pyridinyl)pyrazol-4-yl-acetic acids, process for their preparation and their use as herbicide and plant growth regulator. |
| 07/02/2008 | EP1937664A1 Hydrazide compound and pesticidal use of the same |
| 07/02/2008 | EP1937648A1 Diacyl indazol derivatives as lipase and phospholipase inhibitors |
| 07/02/2008 | EP1937647A1 Condensed pyrazole derivatives as ppar agonists ii |
| 07/02/2008 | EP1937646A1 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
| 07/02/2008 | EP1937645A1 Pyrazoles useful in the treatment of inflammation |
| 07/02/2008 | EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 07/02/2008 | EP1937637A1 New n-alkyl-heterocyclyl carboxamide derivatives |
| 07/02/2008 | EP1937259A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 07/02/2008 | EP1937071A2 Crystalline modifications to pyraclostrobin |
| 07/02/2008 | EP1727805B1 1-phenyl and 1-pyridylpyrazole derivatives and their use as pesticides |
| 07/02/2008 | EP1569911B1 Indazole derivatives as crf antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | CN101209995A 5-amidopyrazole derivatives, preparation method and use thereof |
| 07/02/2008 | CN100398522C Inhibitors of cathepsin S |
| 07/02/2008 | CN100398104C Medicament comprising combination of antithrombotic agent with pyrazolone derivative |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 07/01/2008 | US7393868 AMPA receptor potentiators |
| 07/01/2008 | US7393850 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 07/01/2008 | US7393842 Pyrazole analogs acting on cannabinoid receptors |
| 06/26/2008 | WO2008076223A1 Non-nucleoside reverse transcriptase inhibitors |
| 06/26/2008 | WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | WO2008075353A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | WO2008075118A1 Novel cb1 antagonists and their preparation |
| 06/26/2008 | WO2008075019A1 Modulators of cb1 receptors |
| 06/26/2008 | WO2008075013A1 Modulators of cannabinoid receptor |
| 06/26/2008 | WO2008075012A1 Cb1 receptor modulators |
| 06/26/2008 | WO2008074814A1 Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 06/26/2008 | WO2008074757A1 Organic compounds |
| 06/26/2008 | WO2008074194A1 A process for the preparation of sildenafil and the intermediates thereof |
| 06/26/2008 | WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 06/26/2008 | US20080154045 Process for Producing 1-Substituted-3-Fluoroalkylpyrazole-4-Carboxylate |
| 06/26/2008 | US20080153893 Pyrazole Carboxamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1 |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153812 Novel compounds |
| 06/26/2008 | US20080153707 Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi |
| 06/26/2008 | US20080152950 Anthracene derivative and organic electroluminescent device using the same |
| 06/26/2008 | DE102006060598A1 New tetrahydrobenzoisoxazole compounds are mitotic motor protein Eg5 modulators useful to treat and prevent cancer, and to treat e.g. monocyte leukemia, glioblastoma, colon carcinoma, myelotic leukemia and lymphatic leukemia |
| 06/26/2008 | CA2695613A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | CA2673359A1 Cb1 receptor modulators |
| 06/26/2008 | CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | CA2673177A1 Modulators of cb1 receptors |
| 06/26/2008 | CA2672521A1 Pyrazole derivatives as protein kinase inhibitors |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935886A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 06/25/2008 | EP1934185A1 Pyrazole compounds that modulate hsp90 activity |
| 06/25/2008 | EP0986382B1 Raf kinase inhibitors |
| 06/25/2008 | CN101208306A Pyrazole compounds and antidiabetes agents containing the same |
| 06/25/2008 | CN101208297A Antiviral compounds and methods |
| 06/25/2008 | CN101208082A Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/25/2008 | CN101205202A Substituted benzene urea compounds as well as preparation and uses thereof |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390835 Aralkyl amines as cannabinoid receptor modulators |
| 06/24/2008 | US7390827 Herbicides for selectively controlling broadleaf and gramineous weeds in crops of useful plants, especially in rice crops |
| 06/24/2008 | US7390810 Pyrazole-amine compounds useful as kinase inhibitors |
| 06/24/2008 | US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma |
| 06/24/2008 | US7390797 Fused indazole compounds |
| 06/19/2008 | WO2008073825A1 Lxr and fxr modulators |
| 06/19/2008 | WO2008072745A1 Process for production of anthranilamide compound |
| 06/19/2008 | WO2008072053A2 Substituted arylpyrazoles |
| 06/19/2008 | WO2008071398A1 Sulfonamides and their use as a medicament |
| 06/19/2008 | WO2008045371A3 N-substituted-azacyclylamines as histamine-3 antagonists |
| 06/19/2008 | WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 06/19/2008 | WO2007069020A3 N-hydroxyamide derivatives possessing antibacterial activity |
| 06/19/2008 | US20080146815 Pdk-1/akt signaling inhibitors |
| 06/19/2008 | US20080146660 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 06/19/2008 | US20080146643 Combination |
| 06/19/2008 | US20080146625 Oxime glucokinase activators |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/19/2008 | US20080146614 Therapeutic Agents |
| 06/18/2008 | EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 06/18/2008 | EP1932830A1 Sulfonamides and their use as a medicament |
| 06/18/2008 | EP1931641A2 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI |
| 06/18/2008 | EP1931640A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 06/18/2008 | EP1931639A2 Process |
| 06/18/2008 | EP1931348A2 Monocyclic and bicyclic compounds and methods of use |
| 06/18/2008 | EP1931336A1 Tetrahydro-indazolyl cannabinoid modulators |
| 06/18/2008 | EP1931335A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 06/18/2008 | EP1556359B1 Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases |
| 06/18/2008 | CN101203136A Crystalline modifications to pyraclostrobin |
| 06/17/2008 | US7388023 Amino acids with affinity for the α2δ-protein |
| 06/17/2008 | US7388021 Novel pyridyl or phenyl ureas and analogues; Purinoreceptors inhibitors; 1-(4-tert-butylphenyl)-3-(2-(3-isopropylphenoxy)pyridin-3-yl)urea; for the treatment of a thromboembolic disorders |
| 06/17/2008 | US7388011 Inhibiting the proteolytic activity of cathepsin S; 4-{3-[5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxy-propyl}-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl-3'-carbonitrile; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 06/17/2008 | CA2501799C Pyrazole compounds for treatment of neurodegenerative disorders |
| 06/12/2008 | WO2008070583A2 Thrombopoietin mimetics |
| 06/12/2008 | WO2008070507A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/12/2008 | WO2008069069A1 Amide compound and salt thereof, and biofilm formation inhibitor or biofilm remover using the same |